WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from 4,105,770,633 shares to 4,107,272,633 shares.

The change resulted from the issuance of 2,000 new ordinary shares at HKD4.67 per share, as well as the issuance of 1,500,000 new ordinary shares at HKD1.29 per share under the Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended). These issuances amount to a combined total of 1,502,000 new shares.

Following the completion of these transactions on 19 November 2025, the company’s total number of issued shares stands at 4,107,272,633. No repurchase, redemption, or cancellation of shares was disclosed in the announcement.